Munich, Germany

Hilke Sudergat


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):

Title: Hilke Sudergat: Innovating Cancer Treatment through Dihydropyrimido Derivatives

Introduction: Hilke Sudergat is a remarkable inventor based in Munich, Germany, recognized for her groundbreaking work in the field of pharmaceuticals. With a focus on protein kinase inhibitors, her innovative contributions aim to combat diseases influenced by src tyrosine kinases, particularly in the domain of oncology.

Latest Patents: Sudergat holds a notable patent for "Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives." The compounds described in her patent are formulated as inhibitors targeting protein kinases, specifically the src family tyrosine kinases. This innovative research is pivotal for developing treatments for cell proliferative disorders, including cancer. The patent also details methods for synthesizing these compounds and outlines their potential applications in pharmaceutical compositions.

Career Highlights: Currently, Hilke Sudergat is an integral part of Hoffmann-La Roche Inc., a leading pharmaceutical company. Her role involves extensive research and development, contributing to the advancement of medical treatments that address serious health issues affecting millions worldwide.

Collaborations: Throughout her career, Sudergat has collaborated with esteemed colleagues, including Jianping Cai and Nikolaos Dimoudis. These partnerships reflect her commitment to collaborative innovation in the scientific community, fostering the exchange of ideas and expertise that enhance research outcomes.

Conclusion: Hilke Sudergat’s contributions as an inventor exemplify the critical role of innovation in healthcare. Her work on amino-substituted dihydropyrimido derivatives not only advances our understanding of targeted cancer therapies but also highlights the importance of collaboration in achieving significant scientific breakthroughs. As she continues to push the boundaries of research in the pharmaceutical industry, Sudergat remains a pivotal figure in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…